Literature DB >> 21533875

Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.

T Welte1.   

Abstract

Morbidity and mortality in patients with moderate to severe community-acquired pneumonia (CAP) is a global problem, and CAP is a leading cause of death due to infectious diseases. Prompt initiation of expanded-spectrum antimicrobials is essential for the prevention of unnecessary mortality and complications in patients, particularly in the elderly and other at-risk populations, and the treatment decisions made by practitioners have important implications for healthcare systems when hospitalization is required. Empirical antimicrobial treatment and the appropriate management of CAP patients will initially require the proper assessment of severity and patient risk for increased mortality, as well as risk factors for difficult-to-treat bacteria. This review will examine risk factors and scoring systems that may be predictive of moderate to severe CAP, which is often linked to increased risk of mortality. Understanding and recognizing potential risk factors will allow practitioners to proactively identify patients at the highest risk for severe illness or complications, thereby, guiding site-of-care decisions, as well as the choices for empiric antibiotic regimens. The decision to hospitalize a patient with CAP should include not only a clinical perspective and laboratory and radiographic findings, but also at least one objective tool of risk assessment, all in combination with sound clinical judgment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533875     DOI: 10.1007/s10096-011-1272-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  122 in total

1.  The burden of community-acquired pneumonia in Spain.

Authors:  V Monge; V M San-Martín; A González
Journal:  Eur J Public Health       Date:  2001-12       Impact factor: 3.367

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

3.  Sporadic and epidemic community legionellosis: two faces of the same illness.

Authors:  N Sopena; L Force; M L Pedro-Botet; P Barrufet; G Sauca; M García-Núñez; G Tolchinsky; J A Capdevila; M Sabrià
Journal:  Eur Respir J       Date:  2006-09-27       Impact factor: 16.671

4.  Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.

Authors:  A J Clavo-Sánchez; J A Girón-González; D López-Prieto; J Canueto-Quintero; A Sánchez-Porto; A Vergara-Campos; P Marín-Casanova; J A Córdoba-Doña
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.

Authors:  Bertrand Renaud; Eva Coma; Jose Labarere; Jan Hayon; Pierre-Marie Roy; Hélène Boureaux; Fabienne Moritz; Jean François Cibien; Thomas Guérin; Emmanuel Carré; Armelle Lafontaine; Marie Pierre Bertrand; Aline Santin; Christian Brun-Buisson; Michael J Fine; Eric Roupie
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

6.  A hospital study of community acquired pneumonia in the elderly.

Authors:  P Venkatesan; J Gladman; J T Macfarlane; D Barer; P Berman; W Kinnear; R G Finch
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

7.  An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.

Authors:  Victor L Yu; Christine C C Chiou; Charles Feldman; Ake Ortqvist; Jordi Rello; Arthur J Morris; Larry M Baddour; Carlos M Luna; David R Snydman; Margaret Ip; Wen Chien Ko; M Bernadete F Chedid; Antoine Andremont; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2003-07-07       Impact factor: 9.079

8.  Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.

Authors:  Beatriz Rosón; Jordi Carratalà; Núria Fernández-Sabé; Fe Tubau; Frederic Manresa; Francesc Gudiol
Journal:  Arch Intern Med       Date:  2004-03-08

9.  Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

Authors:  Antoni Torres; Javier Garau; Pierre Arvis; Jean Carlet; Shurjeel Choudhri; Amar Kureishi; Marie-Aude Le Berre; Hartmut Lode; John Winter; Robert C Read
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

10.  Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

Authors:  David T Huang; Derek C Angus; John A Kellum; Nathan A Pugh; Lisa A Weissfeld; Joachim Struck; Russell L Delude; Matthew R Rosengart; Donald M Yealy
Journal:  Chest       Date:  2009-04-10       Impact factor: 9.410

View more
  13 in total

1.  Fatty acid-binding proteins as biomarkers of disease severity and outcome in community-acquired pneumonia.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Ann Transl Med       Date:  2016-10

2.  Increased Severity and Mortality of CAP in COPD: Results from the German Competence Network, CAPNETZ.

Authors:  Dionne C W Braeken; Frits M E Franssen; Hartwig Schütte; Mathias W Pletz; Robert Bals; Peter Martus; Gernot G U Rohde
Journal:  Chronic Obstr Pulm Dis       Date:  2015-03-26

3.  Delirium is a predictor of in-hospital mortality in elderly patients with community acquired pneumonia.

Authors:  Filippo Pieralli; Vieri Vannucchi; Antonio Mancini; Maddalena Grazzini; Giulia Paolacci; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2013-09-19       Impact factor: 3.397

4.  Pneumolysin Mediates Platelet Activation In Vitro.

Authors:  Jan Gert Nel; Chrisna Durandt; Timothy J Mitchell; Charles Feldman; Ronald Anderson; Gregory R Tintinger
Journal:  Lung       Date:  2016-05-18       Impact factor: 2.584

5.  Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj.

Authors:  Yasser Mandourah; Assim Al-Radi; Ali Harold Ocheltree; Sara Rashid Ocheltree; Robert A Fowler
Journal:  BMC Infect Dis       Date:  2012-05-16       Impact factor: 3.090

Review 6.  Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.

Authors:  Helen C Steel; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2013-12-25       Impact factor: 4.711

7.  Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.

Authors:  John M McLaughlin; Maribeth H Johnson; Stephen A Kagan; Stephanie L Baer
Journal:  Infection       Date:  2015-05-17       Impact factor: 3.553

8.  Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.

Authors:  Francesco Blasi; Javier Garau; Jesús Medina; Marco Ávila; Kyle McBride; Helmut Ostermann
Journal:  Respir Res       Date:  2013-04-15

9.  Impact of diabetes mellitus on pneumonia mortality in a senior population: results from the NHANES III follow-up study.

Authors:  Jian Liu
Journal:  J Geriatr Cardiol       Date:  2013-09       Impact factor: 3.327

10.  Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort study.

Authors:  Shih-Kai Hung; Yi-Chun Chen; Wen-Yen Chiou; Chun-Liang Lai; Moon-Sing Lee; Yuan-Chen Lo; Liang-Cheng Chen; Li-Wen Huang; Nai-Chuan Chien; Szu-Chi Li; Dai-Wei Liu; Feng-Chun Hsu; Shiang-Jiun Tsai; Michael Wy Chan; Hon-Yi Lin
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.